Clinical panels are small (often 20–80 volunteers) — below the threshold for standard statistical tools
Home Industries Cosmetics & Consumer Health
For Cosmetics & Consumer Health
Personalised products. Small panels. Strong evidence.
Analyse skin response, tolerance markers, or efficacy biomarkers at the individual level — even on the small clinical panels typical of cosmetics R&D.
Industry context
Cosmetics & Consumer Health, today.
Cosmetic and consumer health companies run clinical trials to validate product efficacy, tolerance, and safety. Regulatory bodies and consumer expectations are pushing toward more personalised formulations — requiring genomic and transcriptomic analysis on small volunteer panels.
Key challenges
Three things hold the field back.
Time-to-market pressure demands faster analysis without sacrificing rigour
Growing demand for personalisation requires individual-level data insight, not population averages
How EpiKern fits
A method built for your constraints.
Our method is built for exactly this situation: robust, interpretable results from small clinical panels. Analyse skin response, tolerance markers, or efficacy biomarkers at the individual level — and bring products to market faster with stronger evidence.
Relevant solutions
Where to start.
Talk to us about your Cosmetics projects.
Tell us about your dataset, cohort size, or current bottleneck. We'll review and respond within a few working days.